Skip to content

Clinical trials

Completed Lung Neoplasms trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: Czechia Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20063
20072
20082
20102
20141
20152
20162
20201
20211
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Bristol-Myers Squibb3
European Organisation for Research and Treatment of Cancer - EORTC2
Gustave Roussy, Cancer Campus, Grand Paris2
AbbVie (prior sponsor, Abbott)1
Astellas Pharma Inc1
Carebot s.r.o.1
Celgene1
Eisai Inc.1
Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms25
Carcinoma, Non-Small-Cell Lung14
Adenocarcinoma of Lung2
Ovarian Neoplasms2
Small Cell Lung Carcinoma2
Urinary Bladder Neoplasms2
Biliary Tract Neoplasms1
Breast Neoplasms1
Carcinoma1
Cardiomegaly1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.